Category Archives: Avandia

Featured Stories

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

Smokers More Vulnerable to Joint Replacement Failures

People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits

A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

DeflateGate’s Effects Impact Legal Gambling & the Economy

DeflateGate’s-Effects-Impact-Legal-Gambling-and-the-Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Avandia Mediation Nets Settlement for 20,000 Heart Attack Lawsuits

Pharmaceutical giant GlaxoSmithKline has agreed to settle about 20,000 heart attack lawsuits brought by former users of its Type 2 diabetes medication Avandia. The lawsuits are among thousands more which claim GlaxoSmithKline (GSK) hid data showing the leading diabetes drug … Continue reading

Posted in Avandia, Pharmaceuticals |

Glaxo May Mediate More Avandia Settlements

Last week, we wrote that GlaxoSmithKline Plc agreed to pay $3 billion to resolve federal investigations into how it marketed some of its drugs, including its controversial type 2 diabetes drug, Avandia. Now, a judge is urging the drug maker … Continue reading

Posted in Avandia, Pharmaceuticals |

Glaxo to Settle Avandia, Other Federal Drug Marketing Investigations

GlaxoSmithKline has agreed to pay $3 billion to resolve federal investigations into the marketing of some of its drugs, including the controversial type 2 diabetes drug, < "http://www.yourlawyer.com/topics/overview/avandia">Avandia. According to a report from Bloomberg News, the agreement with the U.S. … Continue reading

Posted in Avandia, Pharmaceuticals |

More Avandia Lawsuits Filed In Illinois

More < "http://www.yourlawyer.com/topics/overview/avandia">Avandia lawsuits have been filed, this time, in Illinois. Most recently, we wrote that eight plaintiffs filed a lawsuit in Texas against GlaxoSmithKline, maker of the once-popular diabetes medication. The two Illinois plaintiffs allege that GlaxoSmithKline should not … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Lawsuit Filed by 8 in Texas

A group of Texas plaintiffs have added to the pile of < "http://www.yourlawyer.com/topics/overview/avandia">Avandia lawsuits heading to court. The 8 individuals filed suit against GlaxoSmithKline alleging Avandia caused them to suffer various heart problems, and are seeking a full refund for … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Lawsuit Filed By 90+ Plaintiffs

A large group of over 90 people who took diabetes drug, < "http://www.yourlawyer.com/topics/overview/avandia">Avandia, have filed a lawsuit against the maker of the controversial medication, GlaxoSmithKline. The 14-count lawsuit seeks over $700,000, including costs, legal fees, and other relief. The Madison … Continue reading

Posted in Avandia, Pharmaceuticals |

Actos, Avandia Linked to Higher Incidence of Eye Disorder

< "http://www.yourlawyer.com/topics/overview/actos">Actos and < "http://www.yourlawyer.com/topics/overview/avandia">Avandia increase the risk that users will develop diabetic macular edema, a serious eye disorder that can lead to blindness. According to a study presented at the American Diabetes Association’s annual meeting in San Diego, people … Continue reading

Posted in Actos, Avandia, Pharmaceuticals |

Chantix Side Effects Not Reported Properly, FDA Says

The U.S. Food and Drug Administration (FDA) just announced that it asked drug maker, Pfizer Inc., to submit—again—a large amount of its adverse event reports from 2010 for < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix, its stop smoking medication, said the Wall Street Journal. On … Continue reading

Posted in Avandia, Pharmaceuticals |

GlaxoSmithKline Close to Settling More Avandia Lawsuits

It looks like GlaxoSmithKline may be preparing to settle more < "http://www.yourlawyer.com/topics/overview/avandia">Avandia lawsuits. According to a report from Bloomberg News, the Avandia settlements would cover roughly 1,000 former Avandia users who sued the company in state courts in Pennsylvania, California … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Named in Texas Wrongful Death Suit

GlaxoSmithKline is facing yet another < "http://www.yourlawyer.com/topics/overview/avandia">Avandia lawsuit, this time for the alleged wrongful death of a Texas man. The Avandia lawsuit claims the fatal heart attacked suffered by James Michael Knight in 2009 was the result of his taking … Continue reading

Posted in Avandia, Pharmaceuticals |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.